跳至主要内容
临床试验/NCT00081003
NCT00081003已完成不适用

The Intraduct Environment: A Novel Approach to Risk Assessment of Women With a Family History of Breast Cancer

Royal Marsden NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2003年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
试验地点
1

研究概览

简要总结

RATIONALE: Screening tests, such as nipple aspiration, ductal lavage, and breast duct endoscopy, may help doctors detect cancer cells early and plan more effective treatment for breast cancer.

PURPOSE: This clinical trial is studying how well nipple aspiration, ductal lavage, and breast duct endoscopy work in detecting cancer cells in healthy women who are at moderate-to-high risk of developing breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the incidence of mild or severe cellular atypia in nipple aspirate fluid of healthy women at moderate to high risk of developing breast cancer, defined by family history or prior atypical biopsy.

Secondary

  • Correlate cellular atypia with breast cancer, biochemical tumor markers, growth factors, and genetic and protein markers in these participants.
  • Determine cancer risk and incidence utilizing these methods of screening in these participants.
  • Observe the natural history of atypia in these participants over a total of 10 years.
  • Determine whether these techniques may serve as supplementary tools in future screening of these participants.

研究设计

研究类型
Interventional
主要目的
Screening

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Significant family history or prior atypical biopsy indicative of a moderate or high risk of developing breast cancer
  • •No concurrent inflammatory breast cancer
  • •Hormone receptor status:
  • •Not specified
  • •PATIENT CHARACTERISTICS:
  • •Menopausal Status
  • •Premenopausal or postmenopausal
  • •Performance status
  • •Not specified
  • •Life expectancy
  • •Not specified
  • •Hematopoietic
  • •Not specified
  • •Not specified
  • •Not specified
  • •No prior allergy to EMLA cream or lidocaine
  • •No severe illness that would preclude study participation
  • •No mental illness or handicap that would preclude study compliance
  • •No concurrent active infection or inflammation in the breast being studied
  • •Not unconscious
  • •Not pregnant
  • •No nursing within the past 12 months
  • •PRIOR CONCURRENT THERAPY:
  • •Biologic therapy
  • •Not specified
  • •Chemotherapy
  • •Not specified
  • •Endocrine therapy
  • •Not specified
  • •Radiotherapy
  • •Not specified
  • •No prior subareolar surgery (e.g., microdochectomy or major duct excision) that may disrupt the ductal systems within 2 cm of the nipple
  • •No prior breast implantation on proposed lavage side

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验